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Abstract
Several characteristic morphological and functional differences distinguish arteries from veins. It was thought that hemodynamic forces
shaped these differences; however, increasing evidence suggests that morphogenetic programs play a central role in blood vessel
differentiation. Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by the inappropriate fusion of arterioles
with venules. The genes implicated in this disease, ALK1 and endoglin, may be involved in defining the fundamental boundaries between
arteries and veins. We previously showed that mice lacking Alk1 lost structural, molecular, and functional distinctions between arteries and
veins [Nat. Genet. 26 (2000), 328]. Here, we report that mice lacking endoglin develop arterial–venous malformations and fail to confine
intraembryonic hematopoiesis to arteries. In contrast to Alk1 mutants, endoglin mutants do not show profound vessel dilation or
downregulation of arterial ephrinB2. Finally, our data indicate that a failure in cardiac cushion formation observed in both strains may be
secondary to the peripheral vasculature defect. The phenotypic similarities, yet reduced severity, implicates endoglin as an accessory
coreceptor that specifically modulates Alk1 signaling. We propose that endoglin and Alk1 are necessary for the maintenance of distinct
arterial–venous vascular beds and that attenuation of the Alk1 signaling pathway is the precipitating event in the etiology of HHT.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The vascular system is the earliest organ system to form
in the vertebrate embryo and is an essential foundation upon
which all subsequent growth and development relies. A
functional vascular circuit requires the partitioning of dis-
tinct arterial and venous networks that only interconnect
within the capillary beds of distal target organs. Whereas the
endothelial tubes that make up the early embryonic vascular
plexus are morphologically indistinguishable (Risau and
Flamme, 1995), mature arteries and veins differ in their
arrangement of extracellular matrix, smooth muscle cells,
and other supporting cells that endow specialized mechan-
ical and physiological properties. The molecular mecha-
nisms by which nascent endothelial tubes become differen-
tiated into arteries and veins are just beginning to be
elucidated. It was previously thought that the primitive
vasculature was shaped or remodeled by local environmen-
tal factors, e.g., that hemodynamic forces such as blood
pressure and blood flow dictated the differentiation of a
vessel toward arterial or venous character, depending on the
pressure load required of that vessel (Glagov et al., 1988;
Stehbens, 1996). However, recent data indicate that genetic
mechanisms predetermine the fate of vessel differentiation
before these physiologic forces come into play.
Evidence for a genetic program(s) that directs the devel-
opment of arterial–venous identity is emerging primarily
through the characterization of gene-targeted mice and mu-
tational analysis in zebrafish. The first compelling data arose
from the observation that the transmembrane ligand, eph-
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rinB2, and its cognate tyrosine kinase receptor, EphB4, are
differentially expressed within the arterial and venous en-
dothelium, respectively, of embryonic and extraembryonic
vessels prior to the onset of circulation (Adams et al., 1999;
Gerety et al., 1999; Wang et al., 1998). The targeted dis-
ruption of either ephrinB2 or EphB4 disrupts angiogenic
remodeling of arteries and veins that is likely due to inap-
propriate interactions between arterial and venous angio-
genic sprouts. The Notch signaling pathway has also re-
cently been shown to be an important mediator of arterial
differentiation in zebrafish. Gridlock, a potential target of
the Notch pathway, is detected in bilateral mesodermal
Fig. 1. Eng/ embryos exhibit discrete arteriovenous malformations by E9.0. The injection of India ink into the ventricle of E9.0 wild-type embryos mimics
the expected pattern of blood flow that is ejected from the branchial arches and passes down the length of the DA (red caret), in a rostral-to-caudal direction
(A). In contrast, circulation in both Eng/ (B) and Alk1/ (C) embryos is severely impaired by arteriovenous malformations that shunt blood back to the
heart and bypass flow to the caudal aspect of the DA. Immunostaining of transverse sections at the level of the heart and subcardinal veins with a PECAM
antibody delineates distinct arterial and venous vessels in E8.0 wild-type (D), Eng/ (E), and Alk1/ (F) embryos. Beginning at E8.5, Alk1/ embryos
(I) develop arteriovenous malformations between the DA and CV, and exhibit significant vessel dilation. Arterial and venous endothelial tubes remain distinct
in wild-type (G) and Eng/ (H) embryos. By E9.0, Eng/ embryos (K) develop AVMs between the DA and CV similar to Alk1/ embryos (L); wild-type
embryos (J) maintain the distinction between the DA and CV (contiguous with the sinus venosus in this section). Bar, 100 m. DA, dorsal aorta with red
caret; CV, cardinal vein with blue caret; AVM, arteriovenous malformation with yellow caret.
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stripes that give rise to angioblasts that specifically populate
the dorsal aortae (Zhong et al., 2000). Zhong et al. (2001)
and Weinstein et al. (1995) show that modulation of grid-
lock expression is capable of regulating arterial or venous
cell fate decisions in angioblasts. Moreover, Lawson et al.
(2001, 2002) have described an elegant series of “molecular
Fig. 2. Arteriovenous malformations in Eng/ embryos develop unilaterally between the cardinal vein and dorsal aorta in the midtrunk. Transverse sections through
five planes along the rostral–caudal axis reveal the extent and location of shunting between the dorsal aortae and cardinal veins of E9.5 embryos. Sections were
immunostained with a CD34 antibody to highlight the endothelialized lumens, particularly of arterial vessels. In wild-type embryos, the arterial and venous vessels
are apparent as two distinct tubes in all sections (A, D, G, J, M). In Eng/ embryos, the cranial vessels often appeared more constricted than wildtype, but there
were no apparent AVMs (B). Rostral sections revealed vessels of normal diameter (E, H), with moderate dilation of the DA at the midheart level (K). AVMs in
Eng/ were identified only between the CCV and DA immediately caudal to the heart (N). In sharp contrast, AVMs occur in multiple planes within Alk1/
embryos. Severely dilated endothelialized tubes were apparent in the head (C); between the CA and PHV at the level of the mandibular arch (F); between the ACV
and DA at the level of the cardiac outflow tract (I); between the CV and DA at the midcardiac level (L); and between the CCV and DA below the heart (O). The
neural tube is positioned at the top of each panel. Red arrows point to arteries; blue to veins. Bar, 100m; CCV, common cardinal vein; DA, dorsal aorta; CA, carotid
artery; PHV, primary head vein; ACV, anterior cardinal vein; CV, cardinal vein; AVM, arteriovenous malformation. (P) Diagrammatically illustrates the plane of
each transverse section. (*) indicates the common cardinal vein that empties into the sinus venosus; arterial vessels depicted in red; venous vessels depicted in blue.
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epistasis” experiments in zebrafish that have demonstrated a
requirement for Notch5 in arterial differentiation. Recently,
several Notch pathway-related proteins have been shown to
exhibit arterially restricted expression in murine embryos as
well (Mailhos et al., 2001; Shutter et al., 2000; Villa et al.,
2001). Elucidation of the functional roles for many of these
factors and their relevance to mammalian vascular develop-
ment await further study, yet it is clear that construction of
an artery or vein likely requires a complex cascade of
genetic instructions, whether it be in the initial patterning of
the vessel or in the terminal differentiation and maintenance
of an arterial or venous cell fate decision.
In humans, the loss of normal arterial–venous distinction
between arterioles and venules is exemplified in the vascu-
lar disease, Hereditary hemorrhagic telangiectasia (HHT, or
Rendu-Osler–Weber syndrome) (Azuma, 2000; Guttmacher
et al., 1995; McDonald et al., 2000; Shovlin et al., 1997).
Patients develop arteriovenous malformations that predis-
pose them to hemorrhage, shunting, and paradoxical em-
boli. Human genetic studies have established that HHT is
caused by mutations in both Activin-like kinase receptor 1
(ALK1), a type I TGF signaling receptor, and the type III
(nonsignaling) TGF coreceptor, endoglin (Berg et al.,
1996; Johnson et al., 1996; McAllister et al., 1994). Both are
expressed predominantly in the vascular endothelium at
embryonic and adult stages (Jonker and Arthur, 2002; Li et
al., 1999; Matsubara et al., 2000; Roelen et al., 1997).
Biochemical and cell culture assays imply that endoglin
interacts with multiple TGF receptor complexes and may
function as a rheostat to modulate many divergent signaling
pathways (Barbara et al., 1999; Cheifetz et al., 1992; Lux et
al., 1999; Yamashita et al., 1994). Lux et al. (1999) have
shown that endoglin and Alk1 associate as a signaling
complex on the surface of vascular endothelial cells, yet the
precise role and relationship of these receptors in the patho-
genesis of HHT and in vascular development is incom-
pletely understood.
Previously, we demonstrated a requirement for Alk1
signaling in the establishment of normal molecular, func-
tional, and anatomical distinctions between arteries and
veins (Urness et al., 2000). In the absence of Alk1, we
observed downregulation of arterial marker ephrinB2, the
loss of arterial-specific hematopoiesis, and the development
of AVMs between major arteries and veins. This inability to
maintain distinct arterial and venous vascular beds is con-
sistent with a primary role for ALK1 in HHT. In contrast,
none of the previous reports describing vascular defects in
endoglin-targeted mice, including our own, hinted at a re-
quirement for this protein in arterial–venous differentiation
(Arthur et al., 2000; Bourdeau et al., 1999; Li et al., 1999).
This was surprising given that AVMs are reported in HHT
patients harboring endoglin mutations (Berg et al., 1996;
Guttmacher et al., 1995; Morgan et al., 2002). Moreover, a
direct biochemical association between Alk1 and endoglin
has been previously documented (Lux et al., 1999), suggest-
ing that these two receptors may function in the same
pathway. To address this conundrum, we revisited our
Eng/ mice, specifically examining embryos for evidence
of arteriovenous anomalies. Here, we report the presence of
a discrete arteriovenous malformation that results in the
shunting of blood between the major axial artery and vein of
Eng/ embryos. Furthermore, we detect intravascular he-
matopoietic clusters, which are normally confined to the
arterial endothelium, developing ectopically in the veins of
Eng/ embryos. Taken together, these data suggest that
endoglin, like Alk1, plays a role in regulating arterial–
venous identity. Our Alk1/ and Eng/ mice are the only
murine models of which we are aware that faithfully reca-
pitulate the predominant phenotype, AVM, observed in
HHT. The similarity in phenotypic profiles between
Alk1/ and Eng/ embryos suggests that the endoglin
coreceptor predominantly contributes to a common signal-
ing pathway or functions to directly facilitate Alk1 signal-
ing, rather than to modulate multiple TGF signaling path-
ways.
Previous characterization of endoglin-targeted mice sug-
gested that aberrant cardiac development also contributed to
embryonic lethality (Arthur et al., 2000; Bourdeau et al.,
1999). This finding was confusing given the absence of
overt heart defects in HHT patients. We have observed the
same hypoplastic heart defect in our Alk1/ and Eng/
mice; however, we show here, via heart explant culture, that
this defect is likely to be secondary to the breakdown of the
circulatory network in both models. We conclude that Alk1
and endoglin predominantly act in the peripheral vascula-
ture and play an important role in the demarcation of arterial
and venous vascular beds.
Materials and methods
Mice strains and genotyping
Wildtype, Alk1-deficient mice, and endoglin-deficient
mice were bred onto a C57BL/6J genetic background, and
their genotypes were determined as previously described (Li
et al., 1999; Urness et al., 2000). EphrinB2tlacZ/ mice were
mated with Eng/ or Alk1/, and the resultant
ephrinB2tlacZ//Alk1/ or ephrinB2tlacZ//Eng/ double
mutant embryos were identified by using the following
primer sets: B2F, 5-AGG ACG GAG GAC GTT GCC
ACT AAC; and B2R, 5-ACC ACC AGT TCC GAC GCG
AAG GGA amplified the wild-type ephrinB2 allele;
AB47For, 5-TCG GTT ACG GCC AGG ACA GTC GTT;
and AB48Rev, 5-CGA CGT TCA GAC GTA GTG TGA
CGC G amplified the ephrinB2-tlacZ targeted allele; Alk5F,
5-CAA GCT GGT GAA CTG CAC TTG; and Alk5R,
5-CCA GCA TCA GAG ACA CGT TGT amplified the
wild-type Alk1 locus; Eng2F, 5-CCG ACA GCT GCT
GCC CGA AAG; and Eng2R, 5-GGG AGC ACG CCA
CGG TCC AT amplified the wild-type endoglin locus; po-
lyBF, 5-CAG AAA GCG AAG GAG CAA AG; and po-
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lyBR, 5-CGT ACC GAG CTC GAA TTC AT amplified the
targeted Alk1 or endoglin allele.
India ink dye injections
India ink injections were carried out in E9.0 embryos as
previously described (Srivastava et al., 1997; Urness et al.,
2000). Briefly, embryos were dissected in PBS–Tween
(0.1%) and immediately injected in the ventricle of the heart
with India ink diluted in PBS–Tween to 20%. Particulates
were spun down prior to using a standard Eppendorf injec-
tor and Femtotips. Embryos were photographed immedi-
ately, without fixation, in a pool of PBS.
Immunohistochemistry and X-gal staining
Gestational age was determined by the date of formation
of the copulation plug and confirmed by crown-rump
length, number of somites, and landmarks of neural devel-
opment. Sibling pairs were used for comparison. Whole-
mount immunohistochemistry was performed as previously
described (Hogan, 1994). Antibodies against PECAM-1 and
CD34 were obtained from Pharmingen. Whole-mount de-
tection of -galactosidase activity was carried out by using
standard procedures, with the following modification:
E8.0–E10 embryos were fixed in 0.2% glutaraldehyde, 5
mM EGTA, 2 mM MgCl2, and 100 mM sodium phosphate
buffer for 5–10 min prior to staining (Wang et al., 1998).
Biotinylated Griffonia simplicifolia Lectin I (Vector Labs)
was utilized for the detection of endocardial cells in cross-
section (see Fig. 5).
AV canal endocardial cushion morphogenesis assay
Type I collagen gels (1 mg/ml rat tail collagen; Collab-
orative Research) were prepared in four-well dishes (Nalge
Nunc) and hydrated with OptiMEM medium containing 1%
fetal calf serum (FBS) (Hyclone), ITS (5 g/ml insulin, 5
g/ml transferrin, 5 ng/ml selenium), and antibiotics (50
g/ml streptomycin, 50 U/ml penicillin, and 2.5 g/ml
fungizone) (Gibco). The atrioventricular canals (with asso-
ciated myocardium) from E9.0–E9.5 wild-type, Eng/,
and Alk1/ embryo hearts were dissected in Tyrodes Salt
Solution (Sigma), placed on the surface of drained collagen
gels, and incubated at 37°C in 5% CO2. Explants were
allowed to attach to the collagen gel surface overnight
before adding 100 l of Medium 199 containing 1% FBS,
ITS, and antibiotics. After 48–72 h of incubation, each
explant gel was fixed with 4% paraformaldehyde and placed
on a microscope slide for examination. Mesenchymal cells
were stained by -SMC actin prior to analysis. Only cells
that had invaded the 3D gel were counted. Transformation
of endothelium to mesenchyme, and invasion into the col-
lagen gel, was scored from 0–4 by blinded observers. A
score of 0 represents no cell transformation and invasion.
With transformation and invasion present, 1  1–20 cells; 2
 21–50 cells; 3  51–99 cells; and 4  100 cells.
Invasion of the collagen gel in wild-type, Eng/, and
Alk1/ explants was confirmed by 3D reconstruction of
laser scanning confocal microscopy.
Results
Eng/ and Alk1/ mice develop arteriovenous
malformations between the axial vessels
Previously, we showed that Alk1/ embryos developed
arteriovenous malformations (AVMs) between the dorsal
aortae and cardinal veins during, or immediately prior to,
axial turning (Urness et al., 2000). Although gross vascular
defects were immediately apparent in Alk1/ dissected
embryos, the vasculature of Eng/ embryos appeared rel-
atively normal at the gross level. However, given the rela-
tionship of endoglin to ALK1 and HHT, we set out to
carefully examine Eng/ embryos for the presence of
arteriovenous malformations. We injected dye into the ven-
tricles of wild-type, Alk1/, and Eng/ embryos in order
to assess the blood flow patterns. In a wild-type embryo
(Fig. 1A), the dye exits the ventricle through the branchial
arches and traverses the length of the paired dorsal aortae
(DA), eventually emptying into the yolk sac vasculature. In
Alk1/ and Eng/ embryos, the dye similarly exits the
heart through the branchial arches but flows directly back
into the heart through the sinus venosus due to an apparent
anastamosis of the DA and cardinal vein (CV) (Fig. 1B and
Fig. 3. Arterial ephrinB2 expression is unaffected by endoglin mutation. Strong expression of the ephrinB2-taulacZ transgene is apparent in the dorsal aorta
(carets), caudal domain of the somites, hindbrain, and in the nephritic cords of ephrinB2tlacZ/ embryos in E9.5 embryos (A). Higher magnification views
at E9.0 show expression in the midtrunk DA (carets), nascent intersomitic vessels sprouting from the DA, and in the somites (D). Similar expression is
observed in ephrinB2tlacZ//Eng/ embryos in the rostral aspect of the shunted DA (carets), although the caudal extension of the DA is severely attenuated
due to the shunting from this vessel back into the sinus venosus (B). At higher magnification, expression of the tau-lacZ transgene is clearly maintained in
the patent DA (open caret), as well as in the shunted (atretic) DA (filled caret) of ephrinB2tlacZ//Eng/ embryos (E). Little to no expression is observed
in the shunted dorsal aortae of ephrinB2tlacZ//Alk1/ embryos, although the nonvascular staining is unaffected (C, F). Sectioning of stained whole-mount
embryos resulted in an overall reduction in detectable signal, yet arterial expression was still clearly observed in the DA of ephrinB2tlacZ/ (G) and
ephrinB2tlacZ//Eng/ (H) arteries, including the arterial domain of the unilateral AVM in Eng/ animals. No arterial tau-lacZ expression was observed
in similar sections of ephrinB2tlacZ//Alk1/ embryos (I). The epithelia that border the pericardial peritoneal canal express ephrinB2 (black caret) in
ephrinB2tlacZ/ embryos (G). The sections shown in (H) and (I) are slightly more anterior than that of (G), but this signal is also apparent in
ephrinB2tlacZ//Eng/ and ephrinB2tlacZ//Alk1/ embryos. H, heart; AVM, arteriovenous malformation; DA, dorsal aorta; CV, cardinal vein; S, somite;
NC, nephritic cord.
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Fig. 4. Aberrant intraembryonic hematopoiesis in Eng/ cardinal veins. (A–F) Sections taken through the AGM (aorta gonads mesonephros) region of
E9.75–E10 embryonic trunks. All sections were immunostained with CD34 antibody which recognizes arterial endothelium, including the hemogenic
endothelium of hematopoietic clusters (HC). HC were detected in the fused dorsal aortae of wild-type (A), Eng/ (B), and Alk1/ (C) embryos. (D–F)
Higher magnification reproductions of (A–C). (G–L) Sections taken at the level of the subcardinal vein (SCV). HC were never observed in the venous
vasculature of wild-type embryos (G, J). HC were detected in the subcardinal veins (caret) and vitelline veins (data not shown) of Eng/ (H, K) and Alk1/
(I, L) embryos. Note the aberrant expansion of the CD34 signal (carets) in the veins of Eng/ (K) and Alk1/ (L) by E10.
C). This leads to a striking short circuit of blood flow
predominantly within the rostral region of the trunk. In all
cases, a lateral view of the mutant embryos suggested that
the shunted circuit was far more dilated in Alk1/ than
Eng/ embryos. There was no evidence of this malforma-
tion apparent in embryos heterozygous for either mutation.
To further characterize the nature of the AVM in Eng/
embryos, we prepared sections of embryonic day 8.0, 8.5,
and 9.0 mutant embryos to first delineate the temporal
development of this phenotype. In wild-type embryos, the
two axial vessels, bilaterally paired dorsal aortae (DA) and
cardinal veins (CV), are visible as distinct, clearly parti-
tioned vessels throughout embryonic development (Fig. 1D,
G, and J). As previously described, Alk1/ embryos appear
unremarkable at E8.0 (Fig. 1F), but develop AVMs in 1/10
embryos examined by E8.5 (Fig. 1I). Highly dilated dorsal
aortae, cardinal veins, and AVMs are apparent in all
Alk1/ embryos by E9.0 (Fig. 1L). In most Alk1/ em-
bryos, we observe bilateral AVMs that represent anomalous
DA:CV fusions on both the left and right sides of the
embryo. As shown in Fig. 2, these AVMs occur in multiple
planes in the rostral trunk region of Alk1/ embryos.
Interestingly, AVMs occur later in Eng/ embryos (E9.0),
only develop unilaterally without left–right bias, and are far
less dilated (Fig. 1E, H, and K) than those observed in Alk1
mutants (Fig. 1F, I, and L).
In order to assess the location of AVMs along the ros-
tral–caudal length of the mutant embryos, sections were
taken through the midcranial vasculature (Fig. 2A–C),
branchial arch region (Fig. 2D–F), cardiac outflow tract,
(Fig. 2G–I), mid-heart (Fig. 2J–L), and sinus venosus region
(Fig. 2M–O) of E9.5 embryos. A diagrammatic representa-
tion of these planes is provided in Fig. 2P. Although the
cranial vasculature in wildtype (Fig. 2A) and Eng/ (Fig.
2B) are quite similar, in many cases, the primary head vein
(PHV) and carotid artery (CA) of Eng/ mutants are of
smaller diameter. In striking contrast, the cranial vascula-
ture of the Alk1/ embryos is grossly dilated, with a
complete loss of arterial–venous demarcation (Fig. 2C).
PECAM-1 immunostaining of the luminal endothelium sug-
gests that the integrity of these cavernous cranial vessels is
maintained (data not shown). Sections taken at the plane of
the branchial arches (Fig. 2D–F) and cardiac outflow tract
(Fig. 2G–I) again show the overall similarity between wild-
type and Eng/ embryos, yet Alk1/ embryos exhibit
dilated AVMs. Within the midheart plane (Fig. 2J–L),
Eng/ embryos show some degree of vessel dilation, al-
though no apparent AVMs were observed in these sections.
Sections taken through the sinus venosus, positioned such
that the cardinal vein and DA are delineated (Fig. 2M–O),
reveal the presence of AVMs as discrete fusions between the
CV and DA in Eng/ embryos. This was the only region in
which AVMs were observed in Eng/ embryos. Taken to-
gether, the morphological outcome of Alk1 or endoglin disrup-
tion is similar with regard to AVM formation, yet loss of Alk1
results in a greater frequency of AVMs in a given mutant
embryo. The dilation of the vasculature is also significantly
greater in Alk1/ as opposed to Eng/ embryos.
Arterial ephrinB2 expression is unperturbed in Eng/
arteries, but reduced in Alk1/ arteries
The observation of AVMs between the major arterial and
venous vessels in our Eng/ and Alk1/ mice led us to
investigate the possibility of a failure in endothelial arterial
or venous differentiation as a potential explanation for these
data. Wang et al. (1998) and Gerety et al. (1999) have
shown that ephrinB2 and EphB4 are markers for arterial and
venous vessels, respectively, thus we chose to assess the
expression of these markers in our Eng/ embryos. In situ
hybridizations indicated that the ephrinB2 arterial marker
was downregulated in the absence of Alk1, suggesting a
possible failure in the assignment of arterial identity when
the Alk1 signaling pathway is perturbed (Urness et al.,
2000). To extend these studies to the Eng/ embryos, we
intercrossed our mice to targeted ephrinB2tlacZ/ mice that
were generously provided by David Anderson’s lab. The
number of pups obtained by E9.0 of all possible genotypes
was in accordance with the expected Mendelian ratios. Em-
bryos that were doubly heterozygous for the ephrinB2–tlacZ
transgene and the Alk1- or endoglin-targeted allele exhibited
no obvious defects. Whole-mount staining of ephrinB2tlacZ/
embryos for -galactosidase expression and subsequent sec-
tions through these embryos showed strong staining of the
dorsal aortae, caudal aspect of the somites, the hindbrain,
and the paired nephritic cords (Fig. 3A and D) as previously
shown (Adams et al., 1999; Gerety et al., 1999; Wang et al.,
1998). Staining of ephrinB2tlacZ//Alk1/ E9.0–E9.5 em-
bryos confirmed a downregulation of ephrinB2 specifically
in the vasculature (Fig. 3C and F). Cranial, somitic, and
nephritic cord staining was unaffected as would be expected
given the lack of Alk1 expression in these structures. More-
over, the maintenance of ephrinB2 expression in these do-
mains suggests that the reduced expression in the vascula-
ture is not due to global growth arrest or tissue degradation.
Interestingly, expression of ephrinB2tlacZ/ in Eng/ em-
bryos was not downregulated. The lateral view demon-
strates the maintenance of the signal caudally in the atretic
dorsal aortae of Eng/ embryos (Fig. 3B and E). A higher
magnification view clearly demonstrates expression of eph-
rinB2 in the atretic DA caudal to the AVM, as well as in the
patent DA. In cross-section, the blue product of the -ga-
lactosidase reaction is strongly visible in the dorsal aortae of
the ephrinB2tlacZ/ embryos (Fig. 3G). Expression is also
visible in the epithelia bordering the pericardial peritoneal
canal (caret). The arterial portion of the AVM in
ephrinB2tlacZ//Eng/ embryos shows strong expression
(Fig. 3H), whereas the AVM in ephrinB2tlacZ//Alk1/
embryos is completely devoid of signal (Fig. 3I). Experi-
ments using EphB4tlacZ/ intercrosses and in situ hybrid-
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ization with EphB4 riboprobes were uninformative due to
the poor signal:noise ratio. Thus, in Eng/, unlike Alk1/
embryos, AVM occurs in the presence of ephrinB2, indi-
cating that it may not be a critical determinant of arterial–
venous segregation.
Abnormal hematopoietic cluster formation in Eng/ and
Alk1/ mice
Although ephrinB2, a molecular marker of arterial–ve-
nous identity, was unaffected in Eng/ embryos at E9.5,
there remains a case for a loss of functional identity. He-
matopoietic clusters (HC), a marker of functional arterial-
ization, appear as small bundles of cells budding into the
lumen from the endothelial layer of the DA, vitelline, and
uterine arteries, but they are never observed in the venous
vessels of wild-type embryos. These clusters are the forma-
tive centers for intraembryonic hematopoietic stem cells and
function to seed the liver and give rise to the definitive adult
hematopoietic system (Cumano et al., 1996; Godin et al.,
1995; Medvinsky and Dzierzak, 1996; Muller et al., 1994).
Fig. 4A–F establishes the presence of HC in the dorsal
aortae of wild-type, Eng/, and Alk1/ embryos at
E9.75–E10, as expected. HC and the surrounding endothe-
lial cells of the arterial vessel lumen are detected by immu-
nostaining with anti-CD34 antibodies (Wood et al., 1997).
As previously described in Alk1/ mutants (Urness et al.,
2000), Eng/ embryos exhibit the identical ectopic devel-
opment of intraembryonic hematopoietic clusters in the car-
dinal veins of E10 embryos (Fig. 4H and K). We frequently
observed clusters budding from the vessel wall, arguing that
they did not simply arise in the arterial vessels and migrate
via the shunt into the venous compartments. Exhaustive
scanning of wild-type embryos of the same developmental
age and in the same plane never revealed similar structures
within the cardinal veins. These data argue that the demar-
cation between arterial and venous domains is breached in
the absence of Alk1 or endoglin. In support of this, the
arterial marker CD34 appears to become upregulated in the
subcardinal vein of both Eng/ and Alk1/ embryos
(carets, Fig. 4K and L) at this later stage of development.
CD34 is a cell-surface glycoprotein that is expressed on the
surface of hematopoietic, as well as vascular endothelial
cells (Fina et al., 1990), but is normally expressed at a much
higher level on arterial endothelium. Sections in Fig. 4G–L
lie below the rostral zone of AVMs in both Alk1/ and
Eng/ embryos, thus the CD34 staining is not outlining the
arterial portion of an AVM, but rather, is expressed de novo
in a vessel of venous origin. These data could be indicative
of a progressive conversion of venous endothelium to arte-
rial hemogenic endothelium that is not yet apparent in
younger embryos (Fig. 2N and O). Matching wild-type
littermates show no expression of CD34 in this vein (Fig.
4J).
Cardiac cushion defects in Eng/ and Alk1/ mice are
secondary to the development of arteriovenous
malformations
In addition to the unique defects of the peripheral vas-
culature in Alk1 and endoglin mutants, we and others
(Arthur et al., 2000; Bourdeau et al., 1999) have consis-
tently observed dilated heart tubes and pericardial effusions
in both genotypes by E9.5. Gross cardiac phenotypes were
never observed prior to, or concomitant with, AVM forma-
tion. Observations by us and others (C. Mummery, unpub-
lished results) indicate that Alk1 mRNA is expressed only
transiently in the embryonic endocardium in a brief pulse
around E8.5. Subsequent to this time, expression of Alk1 is
absent or low. Although expression of endoglin in the pe-
ripheral vasculature is consistent with that of Alk1, endoglin
is expressed at a higher level and for a longer period in the
embryonic endocardium as assessed by immunostaining
(data not shown) and by -galactosidase staining of targeted
mice with a lacZ reporter driven by the endoglin promoter
(Jonker and Arthur, 2002). In an effort to define the specific
defect in the Eng/ and Alk1/ hearts, we prepared sec-
tions and analyzed them histologically. Sagittal sections
through wild-type embryos clearly show the endocardial
and myocardial layers and the loosely cellular intervening
compartment, the cardiac cushion (Fig. 5A). In contrast,
both Alk1/ and Eng/ hearts exhibited hypocellular
cardiac cushions (Fig. 5B and C). This phenotype could be
due to general developmental arrest in the absence of Alk1
or endoglin, specific failure in endocardial-to-mesenchymal
transformation, or simply due to physical constraints on
morphological development that are secondary to arterio-
venous malformation.
To determine whether the heart defects in Alk1/ and
Eng/ embryos are secondary to blood flow abnormalities,
or whether these defects define an additional functional role
for Alk1 or endoglin, we examined endocardial cushion
formation in the absence of hemodynamic influences. We
utilized an in vitro heart explant culture system to assess
endocardial cushion morphogenesis in Alk1/ and Eng/
embryonic hearts (Bernanke and Markwald, 1979; Runyan
and Markwald, 1983). Atrioventricular canals (with associ-
ated myocardium) from E9.0–E9.5 wild-type, Eng/, and
Alk1/ embryo hearts were dissected and cultured on the
surface of collagen gels for 48–72 h, followed by fixation
and microscopic examination. Endocardial-to-mesenchymal
transformation (EMT) and collagen invasion were readily
apparent in wild-type explants (Fig. 6A and B). Similarly,
AV cushion explants from Eng/ embryos (Fig. 6C) and
Alk1/ embryos (Fig. 6D) displayed vigorous endothelial-
to-mesenchymal transformation and invasion. Mesenchy-
mal cells were identified on the basis of morphology and by
immunostaining with -SMC actin (data not shown). Inva-
sion was confirmed by scanning confocal microscopy.
Quantitative analysis revealed no difference in EMT be-
tween wild-type and mutant explants (Fig. 6E), nor was
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there any indication of EMT or collagen invasion in control
ventricular explants (data not shown). These data indicate
that the cardiac defects observed in these targeted mice may
not be a direct result of loss of Alk1 or endoglin function,
but rather, secondary to the vascular defects and resultant
hemodynamic influences.
Discussion
Here, we show that loss of the TGF type III coreceptor,
endoglin, results in a failure to maintain proper functional
and structural distinctions between arterial and venous vas-
cular beds. We observed arteriovenous shunting between
the major arterial and venous vessels in Eng/ embryos, as
well as a failure to confine intraembryonic hematopoiesis to
the arterial vasculature. Enhanced expression of CD34, pre-
dominantly an arterial marker, in the venous vessels of
embryonic day 10 Eng/ embryos provides further evi-
dence for a loss of vessel identity. Type I HHT, caused by
mutations in endoglin, is characterized by anomalous fusion
of arterioles and venules leading to intrahepatic and pulmo-
nary arteriovenous shunting (Berg et al., 1996; Guttmacher
et al., 1995; Morgan et al., 2002). Our study presents the
first description of anomalous shunting in Eng/ mice,
consistent with this aspect of the human disease. As we
previously described, targeted disruption of Alk1 results in
similar but more severe vascular defects. These include
more extensive A/V shunting, dramatic vessel dilation, and
the downregulation of ephrinB2 in the arteries. Given the
similarity in phenotypes between Alk1 and endoglin knock-
outs, we suggest that Alk1 and endoglin work coordinately
in a common pathway. The lesser severity, though similar
range of defects, of the Eng/ mutants further suggests
that this accessory protein predominantly functions to mod-
ulate Alk1 signaling rather than to promiscuously modulate
several TGF signaling receptors. Finally, we show that
both endoglin- and Alk1-targeted mice develop a similar
hypoplastic heart defect; however, organ culture suggests
that this defect may be secondary to the early vascular
malformations and resultant hemodynamic disruption. In
summary, these data provide a unified role for endoglin and
Alk1 in HHT, that is, the partitioning of arterial and venous
vascular domains.
Arterial–venous identity can be established during dif-
ferent stages of vascular development. During vasculogen-
esis, the vessels that will ultimately give rise to the arterial
dorsal aortae and cardinal veins are patterned de novo and
assembled from angioblasts in the lateral mesoderm
(Cleaver and Krieg, 1998; Coffin et al., 1991; Coffin and
Poole, 1988; Flamme et al., 1997; Pardanaud et al., 1987,
1989; Pardanaud and Dieterlen-Lievre, 2000; Poole and
Coffin, 1989; Risau and Flamme, 1995). Mutations in grid-
lock, the zebrafish homolog of the human HRT2 gene, result
Fig. 5. Hypoplastic heart defects in Eng/ and Alk1/ hearts. Sagittal sections through wild-type E9.75 ventricles (A) show clearly delineated cardiac
cushions in the atrioventricular canal that separates the atrium from the ventricle. The cardiac jelly is cellularized (arrows) with endocardial cells that have
presumably undergone endocardial-to-mesenchymal transformation. In contrast, the cushion cardiac jelly of Eng/ (B) and Alk1/ (C) hearts appears
largely acellular, although the endocardial layer is well defined. Endocardial cells are labeled with biotinylated lectin that develops as a reddish-brown color.
The sections were counterstained with hematoxylin. cc, cardiac cushion. Bar, 100 M.
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Fig. 6. Endocardial cushion morphogenesis in vitro. Atrioventricular (AV) endocardial cushion explants from E9.25–E9.5 wild-type littermates of an endoglin
het-het intercross (A), and wild-type littermates of an Alk1 het-het intercross (B) were cultured on type I collagen gels and incubated at 37°C in 5% CO2 for
48–72 h. Abundant endothelial-to-mesenchymal transformation and invasion into collagen gels was evident in all wild-type AV canal explants. Similarly,
AV cushion explants from Eng/ embryos (C) and Alk1/ embryos (D) displayed vigorous endothelial-to-mesenchymal transformation and invasion (E).
Negative controls were run in tandem and consisted of explanted AV cushion without the associated myocardium (data not shown). Cellular transformation
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in local patterning defects wherein portions of the DA
vessel proper are missing or blocked (Weinstein et al., 1995;
Zhong et al., 2000). Studies utilizing morpholino knock-
down technology further suggest that gridlock plays a role
in arteriogenesis, consistent with its early expression in
prevasculogenic mesoderm (Zhong et al., 2001). Whether
angioblasts are specified to be arterial or venous before the
assembly of the vessel structure occurs, or whether A/V fate
is assigned after the initial vascular network is laid down, is
not clear; however, lineage tracing studies in zebrafish sug-
gest that some angioblasts may be specified as arterial or
venous prior to the vasculogenic consolidation of discrete
vessels (Zhong et al., 2001). The fact that the major embry-
onic vessels appear to have distinct molecular identities
prior to angiogenic remodeling and circulation suggests that
there are classes of genes and genetic programs that are
specifically required for the formation of arterial or venous
tubes during the earliest stages of vascular patterning (for
review, see Weinstein, 1999). Undoubtedly there will be
additional genes discovered that presage the divergence of
functional differentiation of arteries and veins during, or
prior to, vasculogenesis.
Following the de novo formation of the great vessels, the
process of angiogenesis takes over to sculpt and remodel the
nascent vascular plexus (Flamme et al., 1997; Poole and
Coffin, 1989; Risau, 1997). Sprouting of new microvessels
and regression of older vessels builds on the basic vascular
design that was established during vasculogenesis. The re-
modeling that occurs during angiogenesis may also play a
pivotal role in establishing and/or maintaining distinct arte-
rial and venous vascular beds. Evidence from a number of
gene ablation or ectopic expression studies suggests that,
although the de novo assembly of the great vessels is nor-
mal, failure to properly articulate arterial and venous bound-
aries can occur during angiogenesis (Gerety et al., 1999;
Lawson et al., 2001, 2002; Wang et al., 1998). Similarly, the
loss of Alk1 or endoglin does not disrupt de novo assembly
of the vessels, but the ability to maintain the arterial and
venous beds as distinct circuits is clearly lost.
Failure to establish or maintain proper arterial–venous
boundaries may be related to a disruption of normal sprout-
ing mechanisms during angiogenesis. A loss of arterial and
venous terminal differentiation proteins may account for
this failure. The subclass of ephrin and Eph receptors that
are expressed in the vasculature may represent such termi-
nal differentiation proteins. The ephrins and Ephs were first
identified on the basis of their roles in neuronal patterning
via contact-mediated axonal guidance (Flanagan and
Vanderhaeghen, 1998; Holder and Klein, 1999; Krull et al.,
1997; Wang and Anderson, 1997). These cell surface re-
ceptors allow neurons to distinguish correct partners from
incorrect partners via juxtacrine interactions (Mellitzer et
al., 1999). EphrinB2 and EphB4 are also expressed differ-
entially between the arterial and venous vascular compart-
ments. Mice lacking ephrinB2, EphB4, or double mutants
lacking both EphB2/EphB3 show defective angiogenic re-
modeling (Adams et al., 2001; Gerety et al., 1999; Wang et
al., 1998), suggesting that these proteins may play an anal-
ogous role in maintaining distinct A/V boundaries in the
vasculature. Normal expression of a tau-lacZ transgene un-
der the control of the ephrinB2 promoter, and in the absence
of functional eprhinB2, implies that these factors are not
proximally required for establishing vessel identity, but may
help to maintain segregation of the A/V boundaries via
cell–cell interactions and repulsive cues (Gale and Yanco-
poulos, 1997, 1999; Wang et al., 1998; Yancopoulos et al.,
1998). Inappropriate interactions during angiogenesis be-
tween nascent A/V sprouts is likely to be the basis for the
angiogenic abnormalities observed in mice lacking these
proteins.
Here, and in a previous report (Urness et al., 2000), we
showed that ephrinB2 is downregulated in the absence of
Alk1. We had suggested that sprouting arterial endothelial
cells, lacking ephrinB2 on their cell surface, were no longer
inhibited from fusing with venous endothelial sprouts. This
would result in an effective loss of “functional identity,”
given that factors required to distinguish one cell type from
another appear to have been perturbed. The fact that eph-
rinB2 is expressed normally in our Eng/ embryos, al-
though shunting is still evident, suggests that other proteins
in addition to the ephrin/Ephs, are important for regulating
endothelial sprout interactions and establishing and main-
taining distinct boundaries between arterial and venous en-
dothelial cells. Whereas Alk1 may reside in a regulatory
cascade upstream of ephrinB2, it is possible that endoglin
may similarly regulate A-V boundary formation, yet exert
its effect independently of ephrinB2. Our Alk1 and endoglin
mutant mice should provide valuable resources for the iden-
tification of genes that play fundamental roles in the regu-
lation of arterial–venous differentiation, the guidance and
segregation of endothelial sprouts, and/or in the stabiliza-
tion of arterial–venous identity. Differential gene expres-
sion studies are underway to identify these activities and
have already yielded interesting effector genes.
In addition to the ephrin/Eph family, the Notch family of
receptors and their ligands have recently been implicated as
potential regulators of arteriovenous fate. Lawson et al.
(2001) have shown that mutations in zebrafish Notch5 lead
to downregulation of ephrinB2, abnormalities in angiogenic
remodeling, and shunting between the major axial vessels.
These findings are very similar to what we have described in
Alk1 and endoglin mutants, and seem to be specific to the
and invasion into the collagen gel was assessed and scored from 0 to 4 by blinded observers for all AV cushions. With transformation and invasion present,
1  1–20 cells; 2  21–50 cells; 3  51–99 cells; and 4  100 cells. No quantitative difference was found between wild-type and mutant AV cushions.
Mesenchymal cells were identified by morphology and immunostaining with -SMC actin antibody. Invasion of the collagen gel by mesenchymal cells was
confirmed by 3D reconstruction of laser scanning confocal microscopy.
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angiogenic phase of vascular development. Although sev-
eral Notch receptors and ligands are known to be expressed
in the mammalian vasculature, and many are restricted to
arterial or venous vessels, none have been explicitly impli-
cated in arterial–venous identity or differentiation (Mailhos
et al., 2001; Shutter et al., 2000; Villa et al., 2001). In an
effort to determine whether any of these candidate factors
may be effectors in the Alk1 pathway, we examined the
expression of murine Notch signaling pathway-related
genes Notch1 (Del Amo et al., 1992; Reaume et al., 1992),
Notch3 (Lardelli et al., 1994), and Notch4 (Robbins et al.,
1992; Uyttendaele et al., 1996), Delta-like4 (Shutter et al.,
2000), Jagged1 (Shimizu et al., 1999), and Jagged2 (Lan et
al., 1997), and the murine homolog of gridlock, HRT2
(Nakagawa et al., 1999), via in situ hybridization in Alk1/
or Eng/ embryos. We observed no expression differences
for any of these genes relative to wild-type embryos (data
not shown), suggesting that the Notch pathway is not down-
stream of Alk1 signaling. It will be interesting to recipro-
cally assess the expression of Alk1 and endoglin in these
Notch mutant backgrounds or to perform genetic epistasis
experiments to determine whether Alk1 and endoglin func-
tion within, or independent of, the Notch pathways.
The specific mechanism by which AVM occurs between
the large vessels in Alk1/ and Eng/ embryos remains a
mystery. It is unlikely that AVMs dilate from unregressed
capillaries during failed angiogenic remodeling, at least in
the case of endoglin mutant embryos, because of the dis-
crete and highly reproducible location of the AVM in this
background. It is possible that there are specific regions of
the large vessels that are particularly sensitive to altered
dosages of these gene products that somehow activate the
local endothelial cells to migrate and invade inappropriate
vessels during angiogenic sprouting. Notably, the location
of the AVM in Eng/ mice is a region where the dorsal
aortae and cardinal veins are closely juxtaposed. However,
this fails to explain the development of unilateral AVMs
given that these paired vessels occupy identical positions on
either side of the embryo. The fact that the Eng/ AVM is
randomized with respect to the left–right axis argues against
hemodynamic flow or aberrant axial turning influencing to
the development of this defect. The zebrafish violet beau-
regard mutant, defined by a mutation in the zebrafish or-
tholog of Alk1, also develops AVMs (Roman et al., 2002).
Utilization of real-time microangiography may yield impor-
tant information regarding the exact mechanism of this
AVM formation in zebrafish.
Of the mechanisms governing vascular development, he-
modynamic flow has evolved from being regarded as the
causative agent in the development of arterial–venous iden-
tity, to being regarded recently as a far lesser influence as
more and more genes are shown to play a role in the
development of arterial or venous character prior to the
onset of circulation. In contrast, here, we suggest that he-
modynamics remain a central influence with regard to heart
morphogenesis. Cardiac valve development and subsequent
chamber formation are dependent upon the process of en-
docardial-to-mesenchymal cell transformation (EMT) that
occurs in the atrioventricular canal (AV) and outflow tract
regions of the rudimentary embryonic heart (for review, see
Mjaatvedt, 1999). Inductive TGF signals derived from the
myocardium have been shown to induce the differentiation
of endocardial cells into a mesenchymal population that
invades the acellular cardiac jelly, or endocardial cushion,
separating the endocardial layer from the myocardium
(Boyer et al., 1999; Boyer and Runyan, 2001; Brown et al.,
1996, 1999; Camenisch et al., 2002; Nakajima et al., 1994;
Potts et al., 1991). These nascent mesenchymal cells ulti-
mately give rise to the mitral and tricuspid valves, and
effectively subdivide the embryonic heart into atrial and
ventricular compartments (Eisenberg and Markwald, 1995).
The presence of cushion defects in our Alk1/ and
Eng/ embryos and the association of these genes with
TGF signaling prompted us to examine whether there is a
direct link between loss of Alk1 or endoglin and the devel-
opment of this defect. The in vitro cushion assays reported
here indicate that failure of cushion formation and arrest of
heart development in Alk1/ and Eng/ mice may be a
secondary effect of hemodynamic abnormalities. We ob-
served no difference in transformation or collagen gel infil-
tration between heart explants from our mutant or wild-type
littermates. These data suggest that, when isolated from
AVM-induced hemodynamic forces, Alk1/ and Eng/
endocardial cells are able to develop normally. Given that
the peripheral vascular defects in our Alk1/ and Eng/
mice clearly precede the development of the heart defect,
this was not a surprising result. Moreover, several recent
reports indicate that TGFII is the predominant inductive
signal that regulates EMT, and neither Alk1 nor endoglin
bind this ligand (Bartram et al., 2001; Camenisch et al.,
2002; Letterio and Roberts, 1996; Sanford et al., 1997).
Nonetheless, we could not a priori exclude the possibility of
two independent primary effects of a single gene disruption,
particularly in light of the fact that Alk1 and endoglin are
both expressed in the endocardium (C. Mummery, unpub-
lished data; Jonker and Arthur, 2002). We, as well as two
independent laboratories studying endoglin knock-out mice
(Arthur et al., 2000; Bourdeau et al., 1999), have observed
a phenotype suggestive of a failure in endocardial-to-mes-
enchymal transformation (EMT). Our in vitro EMT assay
was conducted in an effort to correlate the observed in vivo
phenotype with a cellular mechanism; however, we ob-
served no such correlation. These data are suggestive that
the heart defect is secondary to the vascular anomalies, but
not conclusive that Alk1 and endoglin are entirely dispens-
able for heart development. We cannot exclude the possi-
bilities that the in vitro EMT assay is insufficiently sensitive
to detect a difference in cushion development between our
wild-type and knock-out embryos, or that the EMT defect in
vivo may be secondary to other endocardial functions that
require Alk1 or endoglin. Nonetheless, our data dictate
caution in assigning primacy to hypoplastic heart pheno-
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types in a background of mutations that significantly impact
peripheral vascular development. In order to definitively
determine the contributions of Alk1 and endoglin to heart
development, it will be necessary to generate conditionally
targeted mice that ablate these activities solely in the heart
field.
In summary, we would like to propose that both endoglin
and Alk1 are required to maintain distinct A-V boundaries
during angiogenesis. In the absence of these genes, speci-
fication of A-V identity and vessel patterning is most likely
normal, but the differentiation, or “read out,” of the assigned
identity appears compromised. We suggest that failure to
fully differentiate a specific arterial or venous fate results in
promiscuous fusions between naı¨ve endothelial sprouts, and
thereby, an effective loss of “functional identity.” With this
in mind, it is conceivable that the pathophysiology of HHT
may arise from inappropriate anastamoses of undifferenti-
ated nascent vascular sprouts following injury and repair.
Although Hereditary Hemorrhagic Telangiectasia shows au-
tosomal dominant inheritance, it has been proposed that the
AVMs observed in both HHT1 and HHT2 patients may
arise from somatic mutations that lead to localized loss of
heterozygosity (for review, see Jacobson, 2000). If this is
true, our Alk1/ and Eng/ mice may accurately model
the human disease pathology. To determine whether inac-
tivation Alk1 signaling can affect postnatal vascular remod-
eling, we are currently devising strategies to allow condi-
tional inactivation of this receptor.
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